Novo Nordisk Inc. is recalling certain lots of Wegovy (semaglutide) Injection prefilled pens due to the presence of foreign particulate matter, specifically hair found inside a prefilled syringe. Wegovy is a prescription medication used for chronic weight management. Using a contaminated injectable product could lead to serious health complications such as injection site irritation, infection, or more severe systemic reactions. This recall affects 0.5 mg and 1 mg doses distributed nationwide within the United States.
The presence of a hair inside a sterile prefilled syringe can cause inflammation, localized infection, or an immune response at the injection site. If the particulate matter is injected, it poses a risk of vascular irritation or more serious clinical complications depending on the nature of the contamination.
You have 2 options:
Manufactured by Novo Nordisk A/S in Denmark.
Manufactured by Novo Nordisk A/S in Denmark.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.